SPONSOR
Yonsei University
Total Trials
15
Recruiting
15
Phases
Phase 2, Phase 4, Phase 1, Phase 2
Conditions studied: Invasive CancerHealthy VolunteerNo Restriction on DiseaseKidney CancerClear Cell Renal Cell Carcinoma MetastaticSynchronous NeoplasmHormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)BradyarrhythmiaAtrioventricular BlockLeft Bundle Branch Area Pacing
Yonsei University is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Invasive Cancer, Healthy Volunteer, No Restriction on Disease, Kidney Cancer.
The trial portfolio spans Phase 2, Phase 4, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Yonsei University
How many clinical trials has Yonsei University sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by Yonsei University, of which 15 are actively recruiting participants. These trials cover conditions including Invasive Cancer, Healthy Volunteer, No Restriction on Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Yonsei University research focus on?
Yonsei University clinical trials span Invasive Cancer, Healthy Volunteer, No Restriction on Disease, Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Yonsei University clinical trial?
To participate in a Yonsei University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yonsei University trials with current recruitment status updated daily.
Clinical Trials by Yonsei University
NCT06231953
Recruiting
A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers
Invasive Cancer
NCT07622498
Recruiting
The Purpose of This Clinical Trial is to Evaluate the Accuracy of Blood Pressure Measurement of HiCardi M350 Compared to Blood Pressure Measured by Auscultatory Sphygmomanometer in Adult Volunteers (Including Those Meeting Blood Pressure Distribution Requirements) in Accordance With ISO 81060-2:2018
No Restriction on Disease
NCT05753839
Recruiting
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
Kidney Cancer
NCT06837792 Phase 2
Recruiting
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)
NCT05585411
Recruiting
PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial
Bradyarrhythmia
NCT07246668 Phase 2
Recruiting
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT05455918 Phase 2
Recruiting
Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor
Pediatric Germ Cell Tumor
NCT06811519
Recruiting
AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
Heart Failure
NCT05488665
Recruiting
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique
Coronary Artery Disease
NCT04432220 Phase 4
Recruiting
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
NCT02038127
Recruiting
Gangwon PCI Prospective Registry
Coronary Artery Disease
NCT07119528
Recruiting
Application-Based Integrated Care in Patients After Pulse Field Ablation
Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System
NCT06642623 Phase 4
Recruiting
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Diabetes Mellitus, Type 2
NCT05894824 Phase 1, Phase 2
Recruiting
T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Gastric Cancer
NCT07418294
Recruiting
Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study
Hemangioma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology